Uses
What the official label says Ergocalciferol is used for
The FDA label for Ergocalciferol states:
Ergocalciferol is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.
Read the label's “Indications and usage” section (verbatim)
Ergocalciferol is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.
Names & forms
Brand names, forms and strengths
Brand names (from RxNorm; not every brand is still sold): Calcidol, Drisdol.
Generic name: ergocalciferol · RxNorm ID (RxCUI): 4018
| Form | Strengths listed in RxNorm |
|---|---|
| Oral Capsule | 0.05 MG, 1.25 MG |
| Oral Solution | 0.2 MG/ML |
| Oral Tablet | 0.01 MG, 0.05 MG, 0.25 MG, 1.25 MG |
Strengths are listed so you can recognise a product — not as dosing information. Only your prescriber can decide what is right for you.
Appearance
What Ergocalciferol looks like
ergocalciferol 1.25 mg
Torrent Pharmaceuticals Limited
ergocalciferol 1.25 mg
Bionpharma Inc.
ergocalciferol 1.25 mg
Epic Pharma LLC
ergocalciferol 1.25 mg
Chartwell RX, LLC
| Strength | Form | Colour | Shape | Size | Imprint | Score | Labeler |
|---|---|---|---|---|---|---|---|
| ergocalciferol 1.25 mg | capsule | green“Clear Forest Green” | oval | 13 mm | E09 | 1 | Torrent Pharmaceuticals Limited |
| ergocalciferol 1.25 mg | capsule, liquid filled | green | oval | 13 mm | PA140 | 1 | Bionpharma Inc. |
| ergocalciferol 1.25 mg | capsule | green“clear-pale yellow solution” | oval | 13 mm | PC7 | 1 | Epic Pharma LLC |
| ergocalciferol 1.25 mg | capsule | green | oval | 13 mm | A3 | 1 | Chartwell RX, LLC |
From the product data in each manufacturer's label on DailyMed. Many companies make Ergocalciferol, so your medicine may look different from any shown here. If a pill looks unfamiliar, ask your pharmacist before taking it.
Read the label's “How supplied” section (verbatim)
Capsules of 1.25 mg (50,000 IU vitamin D) of ergocalciferol, USP are clear, forest green, oval, soft gelatin capsules laser printed with “E09” supplied in HDPE bottles: Bottles of 100 - NDC 13668-757-01 Store at 77°F (25°C); excursions permitted between 59° to 86°F (15° to 30°C) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP/NF. Rx Only Manufactured by: Esjay Pharma Private Limited, Tamilnadu, India - 602117 Distributed by: Torrent Pharma INC. Basking Ridge, NJ 07920. 8113605 P3495/01/25 Rev. 09/2026 logo
Safety
Important warnings for Ergocalciferol
Hypersensitivity to vitamin D may be one etiologic factor in infants with idiopathic hypercalcemia. In these cases vitamin D must be strictly restricted. Keep out of the reach of children.
Contraindications — who should not use it (verbatim)
Ergocalciferol is contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D, and hypervitaminosis D.
Warnings and precautions (verbatim excerpt)
Hypersensitivity to vitamin D may be one etiologic factor in infants with idiopathic hypercalcemia. In these cases vitamin D must be strictly restricted. Keep out of the reach of children.
Side effects — opening of the label's adverse reactions section
Hypervitaminosis D is characterized by effects on the following organ system: Renal: Impairment of renal function with polyuria, nocturia, polydipsia, hypercalciuria, reversible azotemia, hypertension, nephrocalcinosis, generalized vascular calcification, or irreversible renal insufficiency which may result in death. CNS: Mental retardation. Soft Tissues: Widespread calcification of the soft tissues, including the heart, blood vessels, renal tubules, and lungs. Skeletal: Bone demineralization (osteoporosis) in adults occurs concomitantly. Decline in the average rate of linear growth and increased mineralization of bones in infants and children (dwarfism) vague aches, stiffness, and weakness. Gastrointestinal: Nausea, anorexia, constipation. Metabolic: Mild acidosis, anemia, weight loss. To report SUSPECTED ADVERSE REACTIONS, contact Torrent Pharma Inc. …
Drug interactions — opening of the label's section
Mineral oil interferes with the absorption of fat-soluble vitamins, including vitamin D preparations. Administration of thiazide diuretics to hypoparathyroid patients who are concurrently being treated with ergocalciferol may cause hypercalcemia.
This is not a complete list of warnings or side effects. Read the full label and talk to your prescriber or pharmacist. To report a side effect to the FDA, use MedWatch.
Resources
If you were hurt at work
Whether a medicine is right for you is a decision for your prescriber. If you were injured on the job, these educational guides explain the next steps and who can help.
- Injured at work? →What to do after a workplace injury and how workers' comp generally works.
- Prescription home delivery →How mail-order pharmacies can deliver prescriptions to your door.
- Find help →Connect with workers' comp attorneys and doctors who take work-injury cases.
- Pharmacies near you →Search local pharmacies by ZIP code.